Archives: Speakers

Dominic Tayler- In 2006 Dominic left UBS to join Cheviot as one of the founding partners. He specialises in investing for private clients, offshore and charities and in particular religious orders. He also sits on the Asset Allocation and UK Equities Committees.

He began his investment management career at Clerical Medical Investment Group in 1991, before joining Credit Suisse Asset Management in 1993, becoming an associate director in 1995. He took his team to Laing & Cruickshank Investment Management in 1999 as an investment director. Following the acquisition of Laing & Cruickshank by UBS in 2004, he was appointed executive director.

Jennifer has 30 years’ experience leading key market and clinical regulatory approvals. She’s developed and executed global strategies for combination products, integrations of acquired companies, mechanical circulatory support devices, transcatheter aortic valves, left atrial appendage closure devices, drug-eluting stents, abdominal and thoracic aortic stent grafts, peripheral balloons/guidewires, vascular surgery grafts/fabrics, and orthopedic implants. Jennifer has engaged in ISO standards committees, serves on the MDIC ENRICHMENT Industry Advisory Council, volunteers with a local Medtech Accelerator for early-stage startups, and is an Adjunct Instructor for the St. Cloud State University Regulatory Affairs and Services master’s program.

Long aims to continue to work in a research environment that allows him to learn, adapt, and lead research teams in new therapeutic areas, with new products, in new countries. He is also focused on continuing to teach, present, and educate clinical researchers of the dynamic and changing pharmaceutical industry.